Stocksigma LogoStocksigma Logo

Solara Active Pharma Schedules Board Meeting for Q2 Results on 16th Oct'26

Solara Active Pharma Sciences announced that its Board of Directors will meet on 16th Oct'26 to consider and approve the standalone and consolidated

Solara Active Pharma Schedules Board Meeting for Q2 Results on 16th Oct'26

Solara Active Pharma Sciences Ltd 路 Intimation 路 16 Oct 2026, 5:30 am

Solara Active Pharma Schedules Board Meeting for Q2 Results on 16th Oct'26 Solara Active Pharma Sciences announced that its Board of Directors will meet on 16th Oct'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities has been closed for designated persons from 1st Oct'26 and will remain shut until 48 hours following the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Solara Active Pharma Sciences Ltd

All Solara Active Pharma Sciences Ltd announcements